Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

BerGenBio AS - Product Pipeline Review - 2013 - New Study Released


Print article Print article
2014-01-27 08:36:02 - New Pharmaceuticals market report from Global Markets Direct: "BerGenBio AS - Product Pipeline Review - 2013"

Global Market Direct's pharmaceuticals report, "BerGenBio AS - Product Pipeline Review - 2013" provides data on the BerGenBio AS's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, BerGenBio AS's corporate website, SEC filings, investor presentations and featured press releases, both from BerGenBio AS and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* BerGenBio AS - Brief BerGenBio AS overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of BerGenBio AS human therapeutic division.
* Overview of pipeline therapeutics

across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of BerGenBio AS with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the BerGenBio AS's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/769439_bergenbio_as_product_pipeline_review_ ..

Reasons to Get this Report

* Evaluate BerGenBio AS's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of BerGenBio AS in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the BerGenBio AS's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with BerGenBio AS.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of BerGenBio AS and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
BerGenBio AS Snapshot
BerGenBio AS Overview
Key Information
Key Facts
BerGenBio AS - Research and Development Overview
Key Therapeutic Areas
BerGenBio AS - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
BerGenBio AS - Pipeline Products Glance
BerGenBio AS - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
BerGenBio AS - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
BerGenBio AS - Drug Profiles
BGB-324
Product Description
Mechanism of Action
R&D Progress
BGB-002
Product Description
Mechanism of Action
R&D Progress
BGB-003
Product Description
Mechanism of Action
R&D Progress
BGB-109
Product Description
Mechanism of Action
R&D Progress
BerGenBio AS - Pipeline Analysis
BerGenBio AS - Pipeline Products by Therapeutic Class
BerGenBio AS - Pipeline Products by Target
BerGenBio AS - Pipeline Products by Route of Administration
BerGenBio AS - Pipeline Products by Molecule Type
BerGenBio AS - Pipeline Products by Mechanism of Action
BerGenBio AS - Recent Pipeline Updates
BerGenBio AS - Dormant Projects
BerGenBio AS - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
BerGenBio AS, Key Information
BerGenBio AS, Key Facts
BerGenBio AS - Pipeline by Indication, 2013
BerGenBio AS - Pipeline by Stage of Development, 2013
BerGenBio AS - Monotherapy Products in Pipeline, 2013
BerGenBio AS - Phase I, 2013
BerGenBio AS - Preclinical, 2013
BerGenBio AS - Discovery, 2013
BerGenBio AS - Pipeline by Therapeutic Class, 2013
BerGenBio AS - Pipeline by Target, 2013
BerGenBio AS - Pipeline by Route of Administration, 2013
BerGenBio AS - Pipeline by Molecule Type, 2013
BerGenBio AS - Pipeline Products by Mechanism of Action, 2013
BerGenBio AS - Recent Pipeline Updates, 2013
BerGenBio AS - Dormant Developmental Projects,2013

List of Figures
BerGenBio AS - Pipeline by Top 10 Indication, 2013
BerGenBio AS - Pipeline by Stage of Development, 2013
BerGenBio AS - Monotherapy Products in Pipeline, 2013
BerGenBio AS - Pipeline by Top 10 Therapeutic Class, 2013
BerGenBio AS - Pipeline by Top 10 Target, 2013
BerGenBio AS - Pipeline by Top 10 Route of Administration, 2013
BerGenBio AS - Pipeline by Top 10 Molecule Type, 2013
BerGenBio AS - Pipeline Products by Top 10 Mechanism of Action, 2013

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com